Basic Information
Basic information for C21orf62-AS1-203-64aa
Peptide Name C21orf62-AS1-203-64aa
Genome Position chr21:32799306-32799497[+]
Species Human
Peptide Sequence MSDFVGYIQIFKLAPLLEGPSILPPKNLQGFLQGHTLGTAFVSNSPAYLSKSWLHSVFLGVPGP
Peptide Length 64
Unique Yes
Grand Average of Hydropathicity 0.3516
Relative Molecular Mass 8020
Experimental Evidences no
lncRNA ID/Name ENSG00000205930;C21orf62-AS1
Transcript ID/Name ENST00000382378;C21orf62-AS1-203
Transcript Length 3352
Coding Ability 0.4538
DNA Sequence Corresponding to Peptide ATGTCTGACTTTGTGGGATATATTCAGATTTTCAAATTGGCTCCTTTACTGGAGGGCCCCTCGATTTTACCACCCAAGAATCTTCAAGGATTTTTGCAGGGACACACTTTGGGTACTGCATTTGTGAGCAATAGCCCTGCTTACCTCTCCAAGTCCTGGCTTCACAGTGTGTTCCTTGGGGTGCCCGGGCCC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :